Why the study?
Because the tricuspid valve is complex and heterogeneous, landmark t-TEER trial results may be difficult to replicate in daily practice as use expands.
This review provides a guide on optimal steps and advanced maneuvers for transcatheter edge-to-edge repair of the tricuspid valve using the Triclip device.
May aid Triclip TEER operators; extends technical literature but leaves open prospective validation.
The use of transcatheter edge-to-edge repair (t-TEER) for tricuspid regurgitation (TR) continues to grow due to its proven clinical results and high safety profile. Yet, because the tricuspid valve is a complex and heterogenous valve, the results of recent landmark t-TEER trials may be difficult to replicate in daily practice as the use of t-TEER expands. Hence, this review is design to review optimal steps and advanced maneuvers for the Triclip (Abbott, MN, Minneapolis), which is the first United States regulatory approved device for t-TEER.
No takes yet. Share an insight, caveat, or question.
Basman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: